Back to VA VANGUARD CAPITAL MANAGEMENT LLC

ELDNELDN
2 quarters

Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in ELEDON PHARMACEUTICALS INC

Yes. Vanguard Capital Management holds 3,417,223 shares of ELDN (Eledon Pharmaceuticals), worth $13.5M, as of its Q2 2026 13F filing. It increased the position by 124,089 shares (+3.8%) from Q1 2026. Vanguard Capital Management has held ELDN in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$13.5M

Current Shares

3.4M

Total Value Change

+$3.3M

Total Shares Change

+124,089

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.4M
+3.8%
$13.5M0.0%$3.94
29
2026-Q1
First report
3.3M
-
$10.1M0.0%$2.50
0

Other major holders of ELDN: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used